CN1338301A - Medicinal pill for preventing and treating hyperosteogeny - Google Patents
Medicinal pill for preventing and treating hyperosteogeny Download PDFInfo
- Publication number
- CN1338301A CN1338301A CN 01142092 CN01142092A CN1338301A CN 1338301 A CN1338301 A CN 1338301A CN 01142092 CN01142092 CN 01142092 CN 01142092 A CN01142092 A CN 01142092A CN 1338301 A CN1338301 A CN 1338301A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- hyperosteogeny
- rhizoma
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of pills for treating retrograde hyperosteogeny is prepared from 24 Chinese-medicinal materials including cistanche, spatholobus stem, dipsacus root, achyranthes root, etc. Its advantages include high curative effect and cure rate up to 91%, short course of treatment and no recurrence.
Description
The present invention relates to a kind of hyperosteogeny medicine that causes because of each osteoarthrosis degenerative change of cervical vertebra, lumbar vertebra and whole body that cures mainly.
The medicine that is used for the treatment of hyperosteogeny at present mainly contains bony spur tablet, this drug price height of ZHUANGGU GUANJIE WAN, the course of treatment is long, curative effect is low, cure rate is low, the part patient is had side effect.
The purpose of this invention is to provide a kind of medicine that cures mainly hyperosteogeny, this medicine all has tangible curative effect to the hyperosteogeny that various osteoarthritis cause, and cost of the present invention is low, curative effect is high, short treating period, curative effect is lasting, cure rate is high, can reach 99% to hyperosteogeny patient effective percentage, cure efficient and can reach 91%.
The present invention adopts following principle to realize: the present invention adopts tonifying kidney, replenishing vital essence and tonifying bone, relaxing muscles and tendons and activating QI and blood in the collateral analgesic principle, reach invigorating the kidney and strengthening the bones, strengthening waist and kidney, life essence-filling, marrow-benefitting, relaxing muscles and tendons to promote blood circulation, promote the absorption of the activity, enhancing body of sclerotin to calcium, quicken partial blood circulation, realizing the purpose of resisting hyperosteogeny, is that main medicine cooperates realization.
Owing to adopt such scheme, can make the present invention treat bone matrix hyperplasia curative effect height, short treating period, cure rate height, the more difficult recurrence in back, can reach 99% to treatment hyperosteogeny effective percentage, cure rate can reach 91%.
Below be the present invention's prescription and processing technology in detail: Rhizoma Drynariae 5 grams, Herba Cistanches 5 grams, Caulis Spatholobi 5 grams, Cortex erythrinae 6 grams, Radix Dipsaci 5 grams, Radix Cyathulae 3 grams, Radix Angelicae Sinensis 6 grams, Ba Ji days 6 grams, Semen Persicae 3 grams, soft anti-rich 3 grams, Fructus Chaenomelis 5 grams, Rhizoma Atractylodis 5 grams, rhizoma corydalis 5 grams, celestial Ganoderma 6 grams, Semen Raphani 3 grams, Donga glue 5 grams, FRUCTUS LYCII BARBARI 10 grams, Cortex Eucommiae 5 grams, Olibanum 3 grams, Myrrha 3 grams, Rhizoma Chuanxiong 5 grams, Radix Aconiti Preparata 3 grams, Radix Aconiti Kusnezoffii Preparata 3 grams, Radix Clematidis 5 grams, XUEDANSHEN 6 grams.
Processing technology of the present invention: with above medicine Seiko screening, remove impurity, abide by ancient processing and concoct after, in the Capsules of 0.5 gram that grinds to the powder jointly, packs into, 60 every bottle of packing.Patient's instructions of taking: 3 times on the one, one time 3-6 grain, one after each meal.
Claims (1)
1. composite medicine for the treatment of hyperosteogeny is characterized in that: it is the medicament that the feedstock production with following weight ratio becomes: Rhizoma Drynariae 5 grams, Herba Cistanches 5 grams, Caulis Spatholobi 5 grams, Cortex erythrinae 6 grams, Radix Dipsaci 5 grams, Radix Cyathulae 3 grams, Radix Angelicae Sinensis 6 grams, Ba Ji days 6 grams, Semen Persicae 3 grams, soft anti-rich 3 grams, Fructus Chaenomelis 5 grams, Rhizoma Atractylodis 5 grams, rhizoma corydalis 5 grams, celestial Ganoderma 6 grams, Semen Raphani 3 grams, Donga glue 5 grams, FRUCTUS LYCII BARBARI 10 grams, Cortex Eucommiae 5 grams, Olibanum 3 grams, Myrrha 3 grams, Rhizoma Chuanxiong 5 grams, Radix Aconiti Preparata 3 grams, Radix Aconiti Kusnezoffii Preparata 3 grams, Radix Clematidis 5 gram, XUEDANSHEN 6 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01142092 CN1338301A (en) | 2001-09-12 | 2001-09-12 | Medicinal pill for preventing and treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01142092 CN1338301A (en) | 2001-09-12 | 2001-09-12 | Medicinal pill for preventing and treating hyperosteogeny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1338301A true CN1338301A (en) | 2002-03-06 |
Family
ID=4676623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01142092 Pending CN1338301A (en) | 2001-09-12 | 2001-09-12 | Medicinal pill for preventing and treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1338301A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1313131C (en) * | 2003-12-04 | 2007-05-02 | 李天祥 | Traditional Chinese medicine for treating neck disease |
| CN101669991B (en) * | 2009-10-10 | 2011-10-12 | 江泽平 | Gendarussa wine and manufacturing method and application thereof |
| CN102772557A (en) * | 2012-08-13 | 2012-11-14 | 冉文强 | Pure traditional Chinese medicine for treating various hyperosteogenys |
| CN103735791A (en) * | 2014-01-24 | 2014-04-23 | 陈有才 | Traditional Chinese medicinal composition for treating lumbar vertebra and sclerotin diseases and preparation method for traditional Chinese medicinal composition |
| CN107320683A (en) * | 2017-06-30 | 2017-11-07 | 范闯法 | A kind of Chinese medicine for treating caput femoris necrosis |
-
2001
- 2001-09-12 CN CN 01142092 patent/CN1338301A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1313131C (en) * | 2003-12-04 | 2007-05-02 | 李天祥 | Traditional Chinese medicine for treating neck disease |
| CN101669991B (en) * | 2009-10-10 | 2011-10-12 | 江泽平 | Gendarussa wine and manufacturing method and application thereof |
| CN102772557A (en) * | 2012-08-13 | 2012-11-14 | 冉文强 | Pure traditional Chinese medicine for treating various hyperosteogenys |
| CN103735791A (en) * | 2014-01-24 | 2014-04-23 | 陈有才 | Traditional Chinese medicinal composition for treating lumbar vertebra and sclerotin diseases and preparation method for traditional Chinese medicinal composition |
| CN103735791B (en) * | 2014-01-24 | 2016-02-10 | 陈有才 | A kind of Chinese medicine composition and preparation method thereof for the treatment of lumbar vertebra, bone diseases |
| CN107320683A (en) * | 2017-06-30 | 2017-11-07 | 范闯法 | A kind of Chinese medicine for treating caput femoris necrosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872442B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN101637589B (en) | Chinese medicinal composition for treating early stage bone injuries and soft tissue injuries and preparation method thereof | |
| CN102283921A (en) | Prescription drug for curing jugular and lumbar herniated disk | |
| CN100336527C (en) | Medicine for treating celevical vertebra disease | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN101181449A (en) | Medicine liqueur for curing osteoproliferation | |
| CN100396321C (en) | Preparation of Chinese traditional medicine for treating hyperosteogeny | |
| CN1546066A (en) | Gastrointestinal ulcer treating Chinese traditional medicine | |
| CN104013769A (en) | Traditional Chinese medicine oral solution for treating osteoporosis | |
| CN1338301A (en) | Medicinal pill for preventing and treating hyperosteogeny | |
| CN1083377A (en) | Yaojingkang (drug for curing lumbar and cervical diseases) | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1943635B (en) | Chinese traditional medicinal preparation for treating bone injuries and osteonosus | |
| CN101095883A (en) | Oral medication for treating barrenness | |
| CN107183274A (en) | Blood-nourishing is soothing the liver cosmetic tea and preparation method thereof and application method | |
| CN1326556C (en) | Chinese medicinal formulation for activating blood circulation, stopping pain and adjusting chemical balance | |
| CN102526418B (en) | Drug for treating lumbar disc herniation and preparation method thereof | |
| CN101732661A (en) | Chinese medicament for treating fracture | |
| CN110201097A (en) | A kind of Chinese medicine composition treating and preventing Hypertrophic osteopathy and preparation method | |
| CN1410082A (en) | Bone strengthening pill and its preparation method | |
| CN100434103C (en) | Chinese medicine composition for treating anemogenous-ache disease | |
| CN1144688A (en) | Medicine for treatment of lumbus and leg paralyses pain | |
| CN101181458B (en) | Chinese medicine preparation for curing fracture | |
| CN101897920A (en) | Chinese medicinal preparation for treating infertility | |
| CN101732428A (en) | Chinese medicament for treating intractable low back pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |